Lista de obras - Hok Pan Yuen - Dominio Público Uruguay

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

artículo científico publicado en 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

artículo científico publicado en 2017

A new method for analysing transition to psychosis: Joint modelling of time-to-event outcome with time-dependent predictors.

artículo científico publicado en 2017

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

artículo científico publicado en 2017

Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk Group

article

Clinical trajectories in the ultra-high risk for psychosis population

artículo científico publicado en 2018

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

artículo científico publicado en 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

artículo científico publicado en 2020

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

artículo científico publicado en 2007

Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effect.

artículo científico publicado en 2015

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

artículo científico publicado en 2008

Dynamic prediction of transition to psychosis using joint modelling

artículo científico publicado en 2018

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

artículo científico publicado en 2016

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

artículo científico publicado en 2014

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

artículo científico publicado en 2018

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

scientific article published on 06 February 2019

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

artículo científico publicado en 2017

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

artículo científico publicado en 2013

Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-up

Managing deliberate self-harm in young people: an evaluation of a training program developed for school welfare staff using a longitudinal research design

artículo científico publicado en 2008

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States

artículo científico publicado en 2005

Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

artículo científico publicado en 2007

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

artículo científico publicado en 2015

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

artículo científico publicado en 2018

Non-reduction in hippocampal volume is associated with higher risk of psychosis

artículo científico publicado en 2002

O5.1. GREY MATTER BRAIN CHANGES IN MEDICATED AND UNMEDICATED FIRST EPISODE PSYCHOSIS: A RANDOMISED PLACEBO-CONTROLLED TRIAL

article by Sidhant Chopra et al published 9 April 2019 in Schizophrenia Bulletin

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

artículo científico publicado en 2018

Obstetric complications and transition to psychosis in an "ultra" high risk sample.

artículo científico publicado en 2005

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

artículo científico publicado en 2020

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

artículo científico publicado en 2017

Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.

artículo científico publicado en 2017

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia

artículo científico publicado en 2002

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

artículo científico publicado en 2003

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

artículo científico publicado en 2012

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

artículo científico publicado en 2002

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

artículo científico publicado en 2009

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

artículo científico publicado en 2019

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

artículo científico publicado en 2018

Relationship between vocational status and perceived stress and daily hassles in first-episode psychosis: an exploratory study

artículo científico publicado en 2012

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

artículo científico publicado en 2004

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

artículo científico publicado en 2018

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

artículo científico publicado en 2018

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

artículo científico publicado en 2013

Social environmental risk factors for transition to psychosis in an Ultra-High Risk population.

artículo científico publicado en 2014

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

artículo científico publicado en 2017

Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm

scientific article published on 19 July 2018

Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.

artículo científico publicado en 2017

Study protocol: the development of a randomised controlled trial testing a postcard intervention designed to reduce suicide risk among young help-seekers

artículo científico publicado en 2009

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

scientific article published on 09 October 2019

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

artículo científico publicado en 2018

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

artículo científico publicado en 2018

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

artículo científico publicado en 2019

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Lista de obras de Hok Pan Yuen

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

A new method for analysing transition to psychosis: Joint modelling of time-to-event outcome with time-dependent predictors.

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk

Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk Group

Clinical trajectories in the ultra-high risk for psychosis population

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effect.

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 y

Dynamic prediction of transition to psychosis using joint modelling

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study

Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-up

Managing deliberate self-harm in young people: an evaluation of a training program developed for school welfare staff using a longitudinal research design

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States

Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

Non-reduction in hippocampal volume is associated with higher risk of psychosis

O5.1. GREY MATTER BRAIN CHANGES IN MEDICATED AND UNMEDICATED FIRST EPISODE PSYCHOSIS: A RANDOMISED PLACEBO-CONTROLLED TRIAL

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

Obstetric complications and transition to psychosis in an "ultra" high risk sample.

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

Relationship between vocational status and perceived stress and daily hassles in first-episode psychosis: an exploratory study

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS.

Sexual trauma increases the risk of developing psychosis in an ultra high-risk "prodromal" population.

Social environmental risk factors for transition to psychosis in an Ultra-High Risk population.

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm

Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.

Study protocol: the development of a randomised controlled trial testing a postcard intervention designed to reduce suicide risk among young help-seekers

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial